SEOUL, South Korea, Dec. 6, 2024 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, announced the signing of a tripartite memorandum of understanding (MOU) for the research and development (R&D) of new products targeting extensively drug-resistant tuberculosis using its Point-of-Care (POC) molecular diagnostic platform "STANDARD M10" (hereinafter, "M10"). The MOU was signed with the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (hereinafter, "RIT/JATA"), and Korea's International Tuberculosis Research Center (hereinafter, "ITRC"), at SD Biosensor's Giheung Office on Nov. 28.
The signing ceremony was attended by HyoKeun Lee (Chief Executive Officer, SDB), Dr. Seiya Kato, (Director, RIT/JATA), and Sangrae Cho (Chief, ITRC), among others. Under this MOU, the three organizations plan to pursue active collaboration on: product research and development; performing research and verifying feasibility; product approval and commercialization, etc., all under the common goal of "research and development of new products for extensively drug-resistant tuberculosis".
"Extensively drug-resistant tuberculosis (XDR-TB)" refers to a form of tuberculosis that is resistant not only to primary drugs used for treatment (multidrug-resistant tuberculosis, MDR-TB, or rifampicin-resistant tuberculosis, RR-TB), but also to fluoroquinolone, a second-line drug, and at least one drug from Group A. The mortality rate of patients who develop resistance to these drugs is known to exceed 25%. Therefore, rapid diagnosis and the use of appropriate medications are crucial. The products for extensively drug-resistant tuberculosis, which will be developed through this MOU with SD Biosensor's POC molecular diagnostic platform M10 are expected to contribute to the eradication of tuberculosis in high-risk Asian countries.
Dr. Seiya Kato, the Director of RIT/JATA said, "We are proud to collaborate with SD Biosensor and the International Tuberculosis Research Center in the development of a molecular diagnostic kit for extensively drug-resistant tuberculosis. This innovation marks a significant step forward in accelerating accurate diagnosis and improving global tuberculosis control efforts."
Dr. Sundae Song, the Chairman of the Board of the ITRC stated, "It is truly meaningful to collaborate on the research and development of new tuberculosis products through this MOU with SD Biosensor, a leader in the global in-vitro diagnostics industry, and RIT/JATA, a world-renowned tuberculosis research institute." He added, "The rapid diagnostic technologies developed through this MOU are expected to significantly shorten the treatment duration for extensively drug-resistant tuberculosis and greatly improve treatment success rates."
HyoKeun Lee, the CEO of SD Biosensor said, "With this MOU as a turning point, we believe that through collaboration of the three parties, we will be able to develop even more innovative and high-performance M10 products for extensively drug-resistant tuberculosis, which will facilitate personalized medication prescriptions." He added, "By continuing exchanges and cooperation between Korea and Japan, we are determined to strengthen our diagnostic capabilities to enable early detection of patients not only in the two countries but across the entire Asian region, and contribute to the global efforts of tuberculosis eradication."
For relevant inquiries, please contact:
Manager Evie Baik, SD Biosensor, Inc. (E-mail: pr@sdbiosensor.com)
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
SD Biosensor Signs Tripartite MOU for R&D of New Products for Extensively Drug-Resistant Tuberculosis with Japan's RIT/JATA and Korea's International Tuberculosis Research Center
- UOTTA Two-Wheeler and Three-Wheeler Battery Swapping Solutions Selected by Treep Mobility Group S.A.C.-
SHANGHAI, Jan. 23, 2025 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that its UOTTA battery-swapping technology for two-wheeler and three-wheeler electric vehicles has been selected by Treep Mobility Group S.A.C. ("Treep Mobility"), a leading Moto Taxi operator in Peru.
U Power has successfully completed the pilot deployment in Peru, which includes 2 operational battery-swapping stations, 1 three-wheeler and 10 two-wheeler electric vehicles. Following this successful pilot, Treep Mobility plans to convert its fleet of traditional fuel-powered vehicles to UOTTA's battery-swapping model, with total orders expected to exceed US$1 million.
Treep Mobility strongly endorses UOTTA's shared battery-swapping model, recognizing its ability to maintain operational hours and revenue when transitioning from traditional fuel vehicles to electric vehicles, while reducing operating costs by 30-40% compared to fuel vehicles. This green and economical transportation solution aligns with environmental development trends.
The UOTTA solution integrates AI technology through its cloud platform and station control system, effectively predicting customer demand and optimizing charging and swapping efficiency to enhance overall operational efficiency. The AI technology also provides targeted solutions based on operational data analysis of vehicles and swapping stations.
"The Moto Taxi market represents an enormous opportunity in Peru and South America," said Jia Li, Chairman and CEO of U Power. "Peru alone has over 100,000 registered Moto Taxis, and South America adds more than 300,000 new electric three-wheeler and two-wheeler motorcycles annually. Treep Mobility's partnership demonstrates that the battery-swapping model is a more economical, convenient, and profitable choice for companies using three-wheeler and two-wheeler motorcycles in passenger transport and delivery services. We believe more companies like Treep Mobility in South America will partner with us, driving sustainable business growth."
About U Power Limited
U Power Limited is a vehicle sourcing services provider, with a vision to becoming an EV market player primarily focused on its proprietary battery-swapping technology, or UOTTA technology, which is an intelligent modular battery-swapping technology designed to provide a comprehensive battery power solution for EVs. Since its operation in 2013, the Company has established a vehicle sourcing network in China's lower-tier cities. The Company has developed two types of battery-swapping stations for compatible EVs and is operating one manufacturing factory in Zibo City, Shandong Province, China. For more information, please visit the Company's website: http://ir.upincar.com/.
Forward-Looking Statements
This press release contains "forward-looking statements". Forward-looking statements reflect our current view about future events. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "could," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "propose," "potential," "continue" or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the U.S. Securities and Exchange Commission.
Contact
U Power Limited
Investor Relations Department
Email: ir@upincar.com
Robin Yang, Partner
ICR, LLC
Email: UPower.IR@icrinc.com
Phone: +1 (212) 475-0415
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
U Power Limited Commences Commercial Operations in Peru with UOTTA Battery-Swapping Technology
